Product NDC: | 0407-1413 |
Proprietary Name: | OMNIPAQUE |
Non Proprietary Name: | Iohexol |
Active Ingredient(s): | 647 mg/mL & nbsp; Iohexol |
Administration Route(s): | INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0407-1413 |
Labeler Name: | GE Healthcare Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018956 |
Marketing Category: | NDA |
Start Marketing Date: | 20060921 |
Package NDC: | 0407-1413-10 |
Package Description: | 10 VIAL, GLASS in 1 BOX (0407-1413-10) > 10 mL in 1 VIAL, GLASS |
NDC Code | 0407-1413-10 |
Proprietary Name | OMNIPAQUE |
Package Description | 10 VIAL, GLASS in 1 BOX (0407-1413-10) > 10 mL in 1 VIAL, GLASS |
Product NDC | 0407-1413 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Iohexol |
Dosage Form Name | INJECTION |
Route Name | INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL |
Start Marketing Date | 20060921 |
Marketing Category Name | NDA |
Labeler Name | GE Healthcare Inc. |
Substance Name | IOHEXOL |
Strength Number | 647 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |